Nasal spray to prevent COVID-19 after a close exposure
Part of Infections, Lungs & breathing clinical trials.
This Phase 3 trial tests whether a medicated nasal spray can stop COVID-19 from starting after you’ve been exposed to someone who recently tested positive. You must start very soon after the person became symptomatic, and you’ll be checked for eligibility based on timing and your health history.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 12 and 85 years old
- Have a close exposure to someone with a recent positive COVID-19 test
- Be able to start the study within 48 hours after the sick person’s symptoms began
- Have a negative rapid COVID-19 test (RAT) within 2 hours before enrollment
- If you can get pregnant, agree to very effective birth control during the study
- Be able and willing to sign consent before any study procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether Astepro nasal spray can help people with mild or no COVID-19 symptoms recover faster. If you have tested positive and are vaccinated, you may qualify.
This trial tests a nasal spray booster for people who have already had 2-3 doses of COVID-19 inactivated vaccine. It studies if the spray is safe and boosts your immune system. You can join if you are healthy, have not had COVID-19 in the last 3 months, and had your last vaccine dose more than 6 months ago.
This trial tests a new nasal spray COVID-19 booster vaccine. It aims to see if the vaccine is safe and produces a strong immune response when given through the nose and inhaled, in people who have already been vaccinated.
This study looks at how your immune system responds to COVID-19 or the flu. It may help researchers understand these infections better, whether you are currently sick or healthy.
This trial tests whether a seawater nasal spray can relieve nasal congestion, runny nose, and other sinus symptoms in people with colds, allergies, or after nose surgery. You will use the spray as directed and answer online questionnaires for up to 3 months.
This trial tests a new nasal spray booster for COVID-19 in adults 18–64 who have already had a primary vaccine series and at least one booster. The goal is to see if it is safe and triggers a good immune response.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.